A

Apellis Pharmaceuticals
D

APLS

27.510
USD
-0.85
(-3.00%)
مغلق
حجم التداول
53,378
الربح لكل سهم
-1
العائد الربحي
-
P/E
-14
حجم السوق
3,422,051,898
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    -0.01500
    (-0.44%)
    3.42500 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    A
    ANAB
    -0.260
    (-1.38%)
    18.570 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    E
    EXEL
    1.750
    (4.99%)
    36.830 USD
    GE
    GE
    -8.950
    (-4.29%)
    199.870 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    المزيد
الأخبار
المقالات

العنوان: Apellis Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.